March 15, 2022
A Delaware federal judge has handed down a mixed bag of rulings in two separate patent suits lodged by genetics tester Natera over cancer-detecting technologies, clearing the way for Natera's case against Inivata to continue, while shooting down Natera's bid to toss counterclaims by Genosity that it was attempting to shut out competition.